Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To evaluate the efficacy of Multiple Micronutrient (MMN) Supplements during pregnancy in reducing the risk of anemia among pregnant women.

Method: A retrospective cohort study was conducted with the supplement of Folic Acid (FA) only and FA plus MMN groups. Data was collected through questionnaires during the first prenatal visit. Hemoglobin levels were extracted from the Laboratory Information System. A total of 4,239 pregnant women who were admitted to Beijing Haidian Maternal & Child Health Hospital between May 2017 and November 2020 was evaluated. Chi-square tests and log-binomial regression were conducted to evaluate the relative risks (RRs) of two groups on the reduction of anemia during pregnancy.

Results: The supplement of MMN was found to significantly decrease the risk of anemia in the later stages of pregnancy. Focusing on the third trimester specifically, the crude RR and adjusted RR were 0.891 and 0.844 respectively. In the second and third trimester of pregnancy, a sufficient monthly intake frequency of MMN(≥ 24 pills) is associated with a lower relative risk of anemia, with a value of 0.897 and 0.809 compared to the group supplement FA only.

Conclusions: The supplement of MMN has been correlated with a reduced risk of anemia in the second and third trimesters of pregnancy. But the efficacy was limited in the first trimester. Frequent and early initiation of supplementation with FA and MMN pills is associated with a more significant reduction in the risk of anemia compare to group supplement of FA only.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177998PMC
http://dx.doi.org/10.1186/s12986-025-00944-xDOI Listing

Publication Analysis

Top Keywords

risk anemia
20
retrospective cohort
8
cohort study
8
supplement mmn
8
third trimester
8
second third
8
pills associated
8
group supplement
8
anemia
7
pregnancy
5

Similar Publications

Background: Following SARS-CoV-2 infection, ~10-35% of COVID-19 patients experience long COVID (LC), in which debilitating symptoms persist for at least three months. Elucidating biologic underpinnings of LC could identify therapeutic opportunities.

Methods: We utilized machine learning methods on biologic analytes provided over 12-months after hospital discharge from >500 COVID-19 patients in the IMPACC cohort to identify a multi-omics "recovery factor", trained on patient-reported physical function survey scores.

View Article and Find Full Text PDF

The development of pulmonary hypertension (PH) after splenectomy is one of the recently controversial issues. This study aims to investigate whether splenectomy itself is an independent risk factor for the development of PH or if the primary contributor to PH development is the underlying condition that necessitated splenectomy. This study was conducted prospectively.

View Article and Find Full Text PDF

Acute kidney injury is one of the most severe complications of severe malaria, with an overall incidence reaching 60% and a mortality rate of up to 45%. We conducted this study to determine the prevalence of acute kidney injury in malaria, acute kidney injury, associated factors and the impact of acute kidney injury on vital prognosis. This was a multicenter, retrospective, descriptive, and analytical study over a 5-year period from January 1, 2019 to December 31, 2023, in the nephrology and infectious diseases departments and intensive care units of Dakar hospitals.

View Article and Find Full Text PDF

Background: Abnormal blood test results are common in both primary and specialist health care. The cause is often multifactorial, and investigations are often conducted across various specialties. We present a patient with incidental disturbances in the blood count with a serious causal relationship.

View Article and Find Full Text PDF

Background: Antithrombotic strategies after percutaneous coronary interventions (PCI) in elderly patients on oral anticoagulant therapy (OAT) are debated due to the balance between ischemic and bleeding risks. Recent guidelines recommend early transitioning from triple antithrombotic therapy to dual antithrombotic therapy, but there are limited data on elderly patients.

Methods: We performed a age-specific analysis of the PERSEO Registry population aimed to compare clinical features, therapeutic strategies, and outcomes of individuals aged ≥ 80 years and < 80 years who were on OAT and underwent PCI with stent.

View Article and Find Full Text PDF